<!DOCTYPE html SYSTEM "about:legacy-compat">
<html class="no-js">
  <head>
    <meta charset="utf-8"/>
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"/>
    <title>DC Code - Chapter 8E. Evaluation of Pharmaceutical Regulation.</title>
    <meta property="st:title" content="Chapter 8E. Evaluation of Pharmaceutical Regulation."/>
    <meta name="description" content="A simple, free browser for the Washington, DC Code"/>
    <meta name="viewport" content="width=device-width"/>
    <link href="https://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700" rel="stylesheet" type="text/css"/>
    <link rel="stylesheet" type="text/css" href="/css/main.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/print.css" media="print"/>
    <script type="text/javascript">
            var _paq = _paq || [];
            _paq.push(['trackPageView']);
            _paq.push(['enableLinkTracking']);
            (function() {
              var u="//analytics.code.dccouncil.us/";
              _paq.push(['setTrackerUrl', u+'piwik.php']);
              _paq.push(['setSiteId', 1]);
              var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
              g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
            })();

          window.searchHost = 'https://search.code.dccouncil.us';
          window.queryUrl = '/v1/search';
          </script>
    <noscript>
      <p>
        <img src="//analytics.code.dccouncil.us/piwik.php?idsite=1" style="border:0;" alt=""/>
      </p>
    </noscript>
  </head>
  <body>
    <header>
      <section class="container">
        <div class="right no-print search" id="search"> </div>
        <h1 id="sitename">
          <a href="/dc/council/code/">Code of the District of Columbia</a>
        </h1>
      </section>
    </header>
    <main class="main container">
      <div class="clearfix" style="width: 100%;">
        <aside id="sidebar" class="col4 quiet">
          <h2>You Are Here</h2>
          <ul class="ancestors">
            <li data-search-path="library" data-search-heading="All Documents">↪ <a href="/">D.C. Law Library</a></li>
            <li data-search-path="library|D.C. Code" data-search-heading="D.C. Code">↪ <a href="/dc/council/code/">Code of the District of Columbia</a></li>
            <li data-search-path="library|D.C. Code|48" data-search-heading="Title 48">↪ <a href="/dc/council/code/titles/48/">Title 48. Foods and Drugs.</a></li>
            <li data-search-path="library|D.C. Code|48|8E" data-search-heading="Chapter 8E">↪ Chapter 8E. Evaluation of Pharmaceutical Regulation.</li>
          </ul>
          <h2>Previous</h2>
          <p>
            <a href="/dc/council/code/titles/48/chapters/8D/">Chapter 8D. Pharmaceutical Education Program.</a>
          </p>
          <h2>Next</h2>
          <p>
            <a href="/dc/council/code/titles/48/chapters/8F/">Chapter 8F. Safe Disposal of Unused Pharmaceuticals.</a>
          </p>
          <h2>Publication Information</h2>
          <h3>Current through Apr. 15, 2017</h3>
          <dl id="recency">
            <dt>Last codified D.C. Law:</dt>
            <dd>
          Law 21-275 effective Apr. 15, 2017</dd>
            <dt>Last codified Emergency Law:</dt>
            <dd>
          Act 21-354 effective Mar. 23, 2016</dd>
            <dt>Last codified Federal Law:</dt>
            <dd>
          Public Law  approved Dec. 14, 2016</dd>
          </dl>
          <section class="cta">
            <p>
              <a href="mailto:code@dccouncil.us?subject=[ERROR]+/dc/council/code/titles/48/chapters/8E/">Report Error</a>
            </p>
            <p>
              <a href="mailto:code@dccouncil.us?subject=[FEEDBACK]+/dc/council/code/titles/48/chapters/8E/">Website Feedback</a>
            </p>
            <p>We cannot respond to questions regarding the law.</p>
          </section>
        </aside>
        <section class="col8 body">
          <h1>Chapter 8E. Evaluation of Pharmaceutical Regulation.</h1>
          <section class="line-group toc child-link">
            <a href="/dc/council/code/sections/48-844.01.html">§ 48–844.01. Short title.</a>
            <a href="/dc/council/code/sections/48-844.02.html">§ 48–844.02. Definitions.</a>
            <a href="/dc/council/code/sections/48-844.03.html">§ 48–844.03. Evaluation.</a>
          </section>
          <section class="content">
            <hr/>
            <h1>§ 48–844.01. Short title.</h1>
            <section>
              <section class="line-group primary-content">
                <p>This chapter may be cited as the “SafeRX Evaluation Act of 2008”.</p>
              </section>
              <br/>
              <section class="line-group annotations">
                <p>
      (<a class="internal-link" href="/dc/council/laws/17-131.html#§501">Mar. 26, 2008, D.C. Law 17-131, § 501, 55 DCR 1659</a>.)
    </p>
                <h4>Delegation of Authority</h4>
                <p>Delegation of Authority pursuant to <a class="internal-link" href="/dc/council/laws/17-131.html">D.C. Law 17-131</a>, the SafeRX Amendment Act of 2008, see Mayor’s Order 2008-94, July 3, 2008 ( 55 DCR 9375).</p>
              </section>
            </section>
            <hr/>
            <h1>§ 48–844.02. Definitions.</h1>
            <section>
              <section class="line-group primary-content">
                <p>For the purposes of this chapter, the term:</p>
                <p class="text-indent-1"><span class="level-num" id="(1)">(1)</span> “Pharmaceutical product” shall have the same meaning as provided in § <a class="internal-link" href="/dc/council/code/sections/3-1201.02.html">3-1201.02</a>(10A)(B)(iii).</p>
                <p class="text-indent-1"><span class="level-num" id="(2)">(2)</span> “Practice of pharmaceutical detailing” shall have the same meaning as provided in § <a class="internal-link" href="/dc/council/code/sections/3-1201.02.html">3-1201.02</a>(10A) [§ <a class="internal-link" href="/dc/council/code/sections/3-1201.02.html">3-1201.02</a>(10A)(A)].</p>
              </section>
              <br/>
              <section class="line-group annotations">
                <p>
      (<a class="internal-link" href="/dc/council/laws/17-131.html#§502">Mar. 26, 2008, D.C. Law 17-131, § 502, 55 DCR 1659</a>.)
    </p>
              </section>
            </section>
            <hr/>
            <h1>§ 48–844.03. Evaluation.</h1>
            <section>
              <section class="line-group primary-content">
                <p class="text-indent-1"><span class="level-num" id="(a)">(a)</span> Within 60 days of September 30, 2010, the Department of Health shall submit to the Council a comprehensive evaluation on the effectiveness of the SafeRx Amendment Act of 2008, effective March 26, 2008 (<a class="internal-link" href="/dc/council/laws/17-131.html">D.C. Law 17-131</a>), which shall include:</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(1)">(1)</span> The number of individuals licensed to engage in the practice of pharmaceutical detailing since March 26, 2008;</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(2)">(2)</span> The number of applicants for licensure to engage in the practice of pharmaceutical detailing not approved by the Board of Pharmacy;</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(3)">(3)</span> The number of applicants for licensure to engage in the practice of pharmaceutical detailing for whom the educational requirements were waived;</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(4)">(4)</span> An assessment of the appropriateness and efficacy of the continuing education requirements established pursuant to <a class="internal-link" href="/dc/council/laws/17-131.html">D.C. Law 17-131</a>;</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(5)">(5)</span> The number of individuals identified as engaging in the practice of pharmaceutical detailing without a license;</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(6)">(6)</span> The amount of fines levied against persons charged with engaging in the practice of pharmaceutical detailing without a license;</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(7)">(7)</span> The total amount and origin of revenue deposited into the Board of Pharmacy Fund;</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(8)">(8)</span> The total amount of funds deposited into the Board of Pharmacy Fund that were used for the administration of the duties of the Board of Pharmacy;</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(9)">(9)</span> The number and types of penalties levied for failure to comply with the requirements of off-label use of medication as set forth in § <a class="internal-link" href="/dc/council/code/sections/48-841.03.html">48-841.03</a>;</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(10)">(10)</span> The number and amount of fines levied for violations as a result of pharmaceutical companies offering gifts or remuneration in violation of § <a class="internal-link" href="/dc/council/code/sections/48-842.03.html">48-842.03</a>;</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(11)">(11)</span> The number of persons who participated in the Pharmaceutical Education Program established by § <a class="internal-link" href="/dc/council/code/sections/48-843.03.html">48-843.03</a>;</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(12)">(12)</span> An assessment of the quality and effectiveness of the Pharmaceutical Education Program based on an assessment of data gathered from those who participated in the program. The data may be gathered by surveying those who participated in the program, using an evaluative instrument developed for that purpose;</p>
                <p class="text-indent-2"><span class="level-num" id="(a)(13)">(13)</span> An assessment of the extent to which regulation of the practice of pharmaceutical detailing has improved the practice of selling, providing information about, or promoting a pharmaceutical product.</p>
                <p class="text-indent-1"><span class="level-num" id="(b)">(b)</span> The evaluation may be used to determine if <a class="internal-link" href="/dc/council/laws/17-131.html">D.C. Law 17-131</a> should be repealed or amended.</p>
              </section>
              <br/>
              <section class="line-group annotations">
                <p>
      (<a class="internal-link" href="/dc/council/laws/17-131.html#§503">Mar. 26, 2008, D.C. Law 17-131, § 503, 55 DCR 1659</a>.)
    </p>
              </section>
            </section>
            <hr/>
          </section>
        </section>
      </div>
    </main>
    <footer>
      <section class="container center">
        <p>The codes and laws on this website are in the public domain.</p>
        <p>
              Please do not scrape. Instead, bulk download the <a href="https://github.com/dccouncil/dc-law-html">HTML</a> or <a href="https://github.com/dccouncil/dc-law-xml">XML</a>.
            </p>
        <p>Powered by the non-profit <a href="http://www.openlawlib.org/">Open Law Library</a>.</p>
      </section>
    </footer>
    <script type="text/javascript" src="/js/main.js"> </script>
  </body>
</html>
